Does Having a Cognitive or Mental Health Condition Automatically Mean Someone Cannot Consent?

Does a diagnosis tell you whether someone can make a research decision?

A prospective participant has schizophrenia. Another has depression. Someone else has mild cognitive impairment, dementia, an intellectual disability, or a history of traumatic brain injury.

Can they give informed consent?

The diagnosis alone does not answer the question. Conditions affecting cognition or mental health can impair consent capacity in some people, at some times, and for some decisions. Other people with the same diagnosis may understand the research, weigh the information meaningfully, and make their own participation decisions without difficulty.

Treating diagnosis as a substitute for assessment risks both under-protection and over-protection: researchers may enroll someone whose capacity is genuinely impaired, or unnecessarily remove decision-making authority from someone entirely capable of consenting.

A condition can affect consent capacity without determining it automatically

Diagnosis and consent capacity answer different questions

A diagnostic label describes a condition, not a particular research decision

OHRP recognizes that diminished decision-making capacity can occur with trauma, some forms of mental illness, dementia, and other conditions. It also notes that impairment may be temporary, progressive, or permanent.

SACHRP goes further by recommending that policies concerning consent capacity should not be limited to specific disorders because impaired capacity occurs across a wide range of conditions and manifests differently among individuals.

The ethically relevant question is therefore not "Does this person have schizophrenia, dementia, depression, or a cognitive disability?" It is "Can this person make the participation decision required by this study at this time?"

People with the same diagnosis can have very different abilities

Mental and cognitive conditions vary in severity, symptoms, course, treatment response, and functional impact. Even within the same diagnosis, one person may experience substantial decisional impairment while another does not.

Capacity can also differ according to what the person is being asked to decide. SACHRP characterizes consent capacity as task-specific and dependent on the nature and complexity of the decision.

A participant may therefore understand a straightforward minimal-risk interview study while finding a complex experimental intervention considerably more difficult to evaluate.

Mental illness does not automatically eliminate rational decision-making

A psychiatric diagnosis should not be treated as evidence that every belief, preference, or decision is irrational. People with mental health conditions routinely make consequential decisions about healthcare, finances, relationships, employment, and everyday life.

Some symptoms can nevertheless interfere with consent. A severe delusion might prevent a participant from appreciating why a study applies to them. Acute mania might substantially affect evaluation of risk in a particular case. Severe depression could affect decision-making in some individuals, while many people with depression retain adequate consent capacity.

The effect of the symptoms on the actual decision matters more than the diagnostic label.

Cognitive impairment exists on a spectrum

Conditions such as dementia, intellectual disability, acquired brain injury, and other cognitive disorders can affect memory, comprehension, executive function, attention, or reasoning to different degrees.

Someone with mild impairment may understand a study adequately when information is presented slowly and clearly. Another person with more substantial impairment may understand basic procedures but be unable to appreciate important risks or compare alternatives sufficiently for the required consent.

A general cognitive deficit therefore does not map perfectly onto research consent capacity.

Do not use a cognitive screening score as an automatic consent cutoff

General cognitive screening instruments can be useful for clinical or research purposes, but they were not necessarily designed to determine whether a person can consent to a specific research protocol.

Consent capacity is task-specific. A numerical score may contribute relevant evidence under an approved assessment procedure, but treating one threshold as an automatic boundary between capable and incapable participants can overlook what the individual actually understands about the study.

The more appropriate approach is to assess the abilities needed for the particular consent decision using a method proportionate to the circumstances.

Capacity can fluctuate with symptoms and circumstances

A participant may have adequate capacity during periods of stability and impaired capacity during an acute episode. Delirium, medication effects, severe psychiatric symptoms, fatigue, intoxication, acute illness, or other factors may alter decision-making ability over relatively short periods.

SACHRP recommends recognizing that consent capacity can improve, fluctuate, or worsen over time and considering reassessment and reconsent when changes are anticipated or discovered.

This creates an important practical question: if the research is not urgent, could the consent discussion reasonably occur when the participant is better able to engage with it?

Support can improve the consent process without manufacturing capacity

Researchers should make reasonable efforts to communicate information in ways participants can use. This may involve simpler language, shorter sections, repetition, visual aids, additional time, breaks, teach-back questions, accessible communication methods, or involving a trusted support person when appropriate.

These measures can reveal abilities obscured by a poorly designed consent process.

Do not confuse communication disability with impaired capacity

A participant may have difficulty speaking, reading, hearing, or using conventional communication without having impaired decision-making ability. Someone with aphasia, for example, may require specialized communication support before researchers can fairly evaluate what they understand.

Similarly, a person who cannot read a consent form may still understand an oral explanation perfectly well.

Researchers should address communication access before interpreting difficulty expressing an answer as inability to make the decision.

An unusual or risky decision does not prove incapacity

Researchers may become concerned when a participant chooses differently from what they expect. Someone might accept a burdensome study for altruistic reasons. Another might decline a potentially beneficial trial because they dislike uncertainty. A participant may place enormous weight on a risk the researcher considers minor.

Capacity does not require participants to share the researcher's values or risk tolerance.

The assessment should focus on whether the participant understands and can use the relevant information, not whether their final choice appears wise.

Do not assume incapacity simply because someone is hospitalized or acutely ill

Hospitalization can increase the likelihood of factors that interfere with consent, including pain, medication, fatigue, delirium, emotional distress, or urgency. It does not itself establish incapacity.

OHRP notes that urgent and emergency medical circumstances can create vulnerability and may require additional protections. Researchers should assess the actual participant and circumstances rather than using location or clinical status as a proxy for capacity.

If capacity is impaired, the participant still remains part of the decision

The 2024 Declaration of Helsinki requires consent from a legally authorized representative for research involving participants incapable of giving free and informed consent, subject to its safeguards. When the participant can provide assent, that assent should also be sought, and dissent should be respected.

This means that impaired capacity should not turn the consent encounter into a private conversation between the researcher and a representative while the participant is ignored.

The participant should receive information appropriate to their abilities and remain involved as far as possible.

Representative consent requires actual authority

A diagnosis does not automatically authorize the nearest relative to consent. Under HHS regulations, who qualifies as a legally authorized representative depends on applicable law.

If the participant lacks capacity, researchers need to determine whether another person may consent on their behalf and who has the required authority. A helpful caregiver and a legally authorized representative are not necessarily the same person.

Excluding everyone with a mental or cognitive condition can also be ethically problematic

Automatic exclusion may appear protective, but it can prevent people with particular conditions from participating in research relevant to their health and can weaken the evidence available for the populations who may ultimately receive an intervention.

SACHRP's recommendations emphasize safeguards tailored to actual impaired consent capacity rather than policies limited to diagnostic categories. The Declaration of Helsinki similarly permits research involving people incapable of consent under specified protections rather than imposing a universal prohibition.

Protection should therefore be proportionate to actual vulnerability. A diagnosis should prompt appropriate attention where relevant, not erase the presumption that the person should be involved in decisions about their own participation whenever possible.

Two people with the same diagnosis may not have the same consent capacity

The diagnosis was relevant because it helped the research team anticipate possible consent difficulties. It was not the capacity determination itself.

Common misconceptions about mental health, cognition, and consent

Use diagnosis to anticipate support needs, not to predetermine the answer

If your study recruits a population in which impaired consent capacity is reasonably foreseeable, plan for that possibility before recruitment. The protocol should describe how capacity concerns will be identified, when a formal assessment will occur, what support participants will receive, how fluctuating capacity will be handled, and what happens when someone cannot provide their own consent.

The ethical balance runs in both directions. Researchers should protect people whose conditions genuinely impair their ability to decide, but they should also protect capable people from having their autonomy removed merely because a diagnostic label makes others uncomfortable.

Before treating a cognitive or mental health condition as relevant to consent

Questions about cognitive and mental health conditions and consent

A diagnosis may raise a question about capacity, but it does not answer it

How to Cite This Guide

This guide is intended to be read, shared, and used in research, teaching, and academic work. If you draw on its ideas, explanations, or other content, please acknowledge the source by citing the guide. Doing so gives appropriate credit and helps your readers locate the original resource.